Stay updated on Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page
- Check7 days agoChange DetectedA new revision entry v3.6.6 has been added to the Record History. This updates the page's version log and supersedes the previous v3.6.5 entry.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision entry, Revision: v3.6.5, was added to the study's record history, replacing Revision: v3.6.4. This indicates a software/interface update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check42 days agoChange DetectedNew revision label v3.6.4 was added to the study record history, replacing the previous v3.6.3. This indicates a minor update to the page history rather than a change to the study data or content.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.6.3 was added to the study record history, replacing the previous v3.6.2.SummaryDifference0.1%

- Check71 days agoChange DetectedThe study record title was updated to use the uHCC abbreviation and corrected wording, and the recruitment status was changed to Active, not recruiting; additional sections such as Contacts/Locations, Eligibility, Outcome Measures, and Arms and Interventions were added.SummaryDifference2%

- Check85 days agoChange DetectedThe Record History page now includes links to 'Check who can join' and 'Find Contact Information' and shows the revision label updated to v3.6.0 from v3.5.5.SummaryDifference0.5%

Stay in the know with updates to Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.